Clinical Trials

Showing trials with last updates posted in 2018.

NCT01590732 | COMPLETED | PHASE1
22 participants

Romidepsin, Ifosfamide, Carboplatin, and Etoposide in Treating Participants With Relapsed or Refractory Peripheral T-Cell Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2018-09-19
Start Date:
2012-10-29
Completion:
2018-05-02
Conditions
  • Mycosis Fungoides
  • Recurrent Anaplastic Large Cell Lymphoma
  • Recurrent Angioimmunoblastic T-Cell Lymphoma
  • Recurrent Enteropathy-Associated T-Cell Lymphoma
  • Recurrent Hepatosplenic T-Cell Lymphoma
  • Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified
  • Refractory Anaplastic Large Cell Lymphoma
  • Refractory Angioimmunoblastic T-Cell Lymphoma
  • Refractory Enteropathy-Associated T-Cell Lymphoma
  • Refractory Hepatosplenic T-Cell Lymphoma
  • Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified
Interventions
  • DRUG
No Results Yet
NCT00962624 | COMPLETED | PHASE2
38 participants

Study of Meningococcal B Vaccine and ACWY Conjugate Vaccine in Healthy Adults

Study Type:
INTERVENTIONAL
Last Updated:
2018-09-19
Start Date:
2010-07-31
Completion:
2011-03-31
Conditions
  • Meningococcal Meningitis, Serogroup A
  • Meningococcal Meningitis, Serogroup B
  • Meningococcal Meningitis, Serogroup C
  • Meningococcal Meningitis, Serogroup Y
  • Meningococcal Meningitis, Serogroup W
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page